# A Formulation Bridging and Food Effect Study of PBI-200 in Healthy Volunteers

> **NCT05690932** · PHASE1 · COMPLETED · sponsor: **Pyramid Biosciences** · enrollment: 33 (actual)

## Conditions studied

- Formulation Bridging
- Food Effect

## Interventions

- **DRUG:** PBI-200 Tablet
- **DRUG:** PBI-200 Capsule
- **DRUG:** PBI-200 Suspension

## Key facts

- **NCT ID:** NCT05690932
- **Lead sponsor:** Pyramid Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-24
- **Primary completion:** 2022-05-23
- **Final completion:** 2022-05-23
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2023-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05690932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05690932, "A Formulation Bridging and Food Effect Study of PBI-200 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05690932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*